Estradiol-17β increases serotonin transporter (SERT) mRNA levels and the density of SERT-binding sites in female rat brain

Molecular Brain Research

Volumn 45, Issue 1, 1997, Pages 13-23

  McQueen, Judith K ^a   Wilson, Helen ^a   Fink, George ^a  

^a ROYAL EDINBURGH HOSPITAL   (United Kingdom)

Author keywords

Affective disorder; Estradiol; Luteinizing hormone; Rat; Serotonin; Transporter

Indexed keywords

CARRIER PROTEIN; ESTRADIOL; ESTRADIOL BENZOATE; GONADOTROPIN; MESSENGER RNA; PAROXETINE; PSYCHOTROPIC AGENT; SEROTONIN; SEROTONIN 2A RECEPTOR; SEROTONIN TRANSPORTER;

AMYGDALOID NUCLEUS; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BINDING SITE; BRAIN REGION; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; FEMALE; GENE EXPRESSION REGULATION; GONADOTROPIN RELEASE; HYPOTHALAMUS VENTROMEDIAL NUCLEUS; IN SITU HYBRIDIZATION; NONHUMAN; OVARIECTOMY; PERIAQUEDUCTAL GRAY MATTER; POSITIVE FEEDBACK; PRIORITY JOURNAL; RAT; SEX DIFFERENCE; THALAMUS;

ANIMALS; AUTORADIOGRAPHY; BRAIN; CARRIER PROTEINS; ESTRADIOL; FEEDBACK; FEMALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; NEURONS; OLIGONUCLEOTIDE PROBES; ORGAN SPECIFICITY; RATS; RATS, WISTAR; RNA, MESSENGER; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SULFUR RADIOISOTOPES; TRANSCRIPTION, GENETIC;

EID: 0031128232     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(96)00233-1     Document Type: Article

References (56)

1. [1] Aghajanian, G.K. and Wang, R.Y., Physiology and pharmacology of central serotonergic neurons. In M.A. Lipton. J.A. DiMascio and K.F. Killam (Eds.), Psychopharmacology: A Generation of Progress. Raven Press, New York, 1978, pp. 171-183.
2. [2] Alheid, G.F., de Olmos, J.S. and Beltramino, C.A., Amygdala and extended amygdala. In G. Paxinos (Ed.), The Rat Nervous System, Academic Press, San Diego, 1995, pp. 495-578.
3. [3] Amara, S.G. and Kuhar, M.J., Neurotransmitter transporters: recent progress, Annu. Rev. Neurosci., 16 (1993) 73-93.
4. [4] Barker, E.L. and Blakely, R.D., Norepinephrine and serotonin transporters. In F.E. Bloom and D.J. Kupfer (Eds.), Psychopharmacology: The Fourth Generation of Progress. Raven Press. New York, 1995, pp. 321-333.
5. [5] Battaglia, G., Sharkey, J., Kuhar, M.J. and De Souza, E.B., Neuroanatomic specificity and time course of alterations in rat brain serotonergic pathways induced by MDMA (3,4-methylenedioxymethamphetamine): assessment using quantitative autoradiography, Synapse, 8 (1991) 249-260.
6. [6] Ben Ari, Y. (Ed.), The Amygdaloid Complex, Elsevier. Amsterdam, 1981.
7. [7] Blakely, R.D., Berson, H.E., Fremean, R.T., Caron, M.G., Peek, M.M., Prince, H.K. and Bradley, C.C., Cloning and expression of a functional transporter from rat brain. Nature (London), 354 (1991) 66-70.
8. [8] Briley, M., Imipramine binding: its relationship with serotonin uptake and depression. In R.A. Green (Ed.), Neuropharmacology of Serotonin, Oxford University Press, Oxford, 1985, pp. 50-78.
9. [9] Clemens, J.A., Sawyer, B.D. and Cerimele, B., Further evidence that serotonin is a neurotransmitter involved in the control of prolactin secretion. Endocrinology. 100 (1977) 692-698.
10. 3H-paroxetine-labeled serotonin uptake sites in rat brain, Synapse, 1 (1987) 488-496.
11. [11] De Vries, G.J., Sex differences in neurotransmitter systems, J. Neuroendocrinol., 2 (1990) 1-13.
12. 2 receptor mechanism plays a key role in the proestrous surge of luteinizing hormone in the rat, Psychoneuroendocrinology, 19 (1994) 395-399.
13. [13] Everitt, B.J., Morris, K.A., O'Brien, A. and Robbins, T.W., The basolateral amygdala-ventral striatal system and conditioned place preference: further evidence of limbic-striatal interactions underlying reward-related processes. Neuroscience, 42 (1991) 1-18.
14. [14] Farmer, C.J., Isakson, T.R., Coy, D.J. and Renner, K.J., In vivo evidence for progesterone dependent decreases in serotonin release in the hypothalamus and midbrain central grey: relation to the induction of lordosis, Brain Res., 711 (1996) 84-92.
15. [15] Fink, G., The GW Harris lecture: 'steroid control of brain and pituitary function', Q. J. Exp. Physiol., 73 (1988) 257-293.
16. [16] Fink, G., Molecular principles from neuroendocrine models: steroid control of central neurotransmission, Prog. Brain Res., 100 (1994) 139-147.
17. [17] Fink, G., The psychoprotective action of estrogen is mediated by central serotonergic as well as dopaminergic mechanisms. In A. Takada and G. Curzon (Eds.), Serotonin in the Central Nervous System and Periphery, Elsevier, Amsterdam, 1995, pp. 175-182.
18. [18] Fink, G., Sumner, B.E.H., Rosie, R., Grace, O. and Quinn, J.P., Estrogen control of central neurotransmission: effect on mood, mental state and memory, Cell. Mol. Neurobiol., 16 (1996) 325-344.
19. [19] Fuller, R.W., Drugs altering serotonin synthesis and metabolism. In R.A. Green (Ed.), Neuropharmacology of Serotonin, Oxford University Press, Oxford, 1985, pp. 1-20.
20. 1A receptor antagonist and an SSRI in vivo: effects on 5-HT cell firing and extracellular 5-HT, Br. J. Pharmacol., 115 (1995) 1054-1070.
21. [21] Gregoire, A.J.P., Kumar, R., Everitt, B., Henderson, A.F. and Studd, J.W.W., Transdermal oestrogen for treatment of severe postnatal depression, Lancet, 347 (1996) 930-933.
22. [22] Henderson, S.R., Baker, C. and Fink, G., Oestradiol-17β and pituitary responsiveness to luteinizing hormone releasing factor in the rat: a study using rectangular pulses of oestradiol-17β monitored by non-chromatographic radioimmunoassay, J. Endocrinol., 73 (1977) 441-453.
23. [23] Hensler, J.G., Ferry, R.C., Labow, D.M., Kovachich, G.B. and Frazer, A., Quantitative autoradiography of the serotonin transporter to assess the distribution of serotonergic projections from the dorsal raphe nucleus, Synapse, 17 (1994) 1-15.
24. [24] Iversen, L.L., Uptake mechanisms for neurotransmitter amines, Biochem. Pharmacol., 23 (1974) 1927-1935.
25. [25] Jacobs, B.L. and Fornal, C.A., Activity of brain serotonergic neurons in the behaving animal, Pharmacol. Rev., 43 (1991) 563-578.
26. [26] Jakab, R.L. and Leranth, C., Septum. In G. Paxinos (Ed.), The Rat Nervous System, Academic Press, San Diego, 1995, pp. 405-442.
27. [27] Kaplan, H.I. and Sadock, BJ., Comprehensive Textbook of Psychiatry, Williams and Wilkins, Baltimore, 1985.
28. [28] Kelly, P.A.T., Ritchie, I.M., McBean, D.E., Sharkey, J. and Olverman, H.J.. Enhanced cerebrovascular responsiveness to hypercapnia following depletion of central serotonergic terminals, J. Cereb. Blood Flow Metab., 15 (1995) 706-713.
29. [29] Klaiber, E.L., Broverman, D.M., Vogel, W. and Kobayashi, Y., Estrogen therapy for severe persistent depressions in women, Arch. Gen. Psychiatry, 36 (1979) 550-554.
30. [30] Lesch, K.P., Aulakh, C.S., Wolozin, B.L., Tolliver, T.J., Hill, J.L. and Murphy, D.L., Regional brain expression of serotonin transporter mRNA and its regulation by reuptake inhibiting antidepressants, Mol. Brain Res., 17 (1993) 31-35.
31. [31] Maes, M. and Meltzer, H.Y., The serotonin hypothesis of major depression. In F.E. Bloom and D.J. Kupfer (Eds.), Psychopharmacology: The Fourth Generation of Progress, Raven Press, New York, 1995, pp. 933-944.
32. [32] McEwen, B.S., Non-genomic and genomic effects of steroids on neural activity, Trends Pharmacol. Sci., 12 (1991) 141-147.
33. 3H-imipramine to rat neuronal membranes, Psychopharmacology, 89 (1986) 436-439.
34. [34] Meltzer, H.Y., Role of serotonin in depression, Ann. N.Y. Acad. Sci., 600 (1990) 486-500.
35. 3H]paroxetine binding in the cerebral cortex and dorsal hippocampus of gonadectomized male and female rats, Brain Res., 601 (1993) 299-302.
36. [36] Miller, M.A., Urban, J.H. and Dorsa, D.M., Steroid dependency of vasopressin neurons in the bed nucleus of the stria terminalis by in situ hybridization. Endocrinology, 125 (1989) 2335-2340.
37. [37] Montgomery, J.C., Brincat, M. and Tapp, A., et al., Effect of oestrogen and testosterone implants on psychological disorders in the climacteric, Lancet, i (1987) 297-299.
38. [38] Morello, H., Caligaris, L., Haymal, B. and Taleisnik, S., Inhibition of proestrous LH surge and ovulation in rats evoked by stimulation of the medial raphe nucleus involves a GABA-mediated mechanism, Neuroendocrinology, 50 (1989) 81-87.
39. [39] Morello, H. and Taleisnik, S., The inhibition of proestrous LH surge and ovulation in rats bearing lesions of the dorsal raphe nucleus is mediated by the locus coeruleus, Brain Res., 440 (1988) 227-231.
40. [40] Ogilvie, A.D., Battersby, S., Bubb, V.J., Fink, G., Harmar, A.J., Goodwin, G.M. and Smith, C.A.D., Polymorphism in serotonin gene associated with susceptibility to major depression, Lancet, i (1996) 731-733.
41. [41] Paxinos, G. and Watson, C., (Eds.) The Rat Brain in Stereotaxic Coordinates, 2nd Ed., Academic Press, Sydney, 1986.
42. [42] Pepin, M.-C., Govindan, M.V. and Barden, N., Increased glucocorticoid receptor gene promoter activity after antidepressant treatment, Mol. Pharmacol., 41 (1992) 1016-1022.
43. [43] Pfaff, D. and Keiner, M., Atlas of estradiol-concentrating cells in the central nervous system of the female rat, J. Comp. Neurol., 151 (1973) 121-158.
44. [44] Price, J.L., Thalamus. In G. Paxinos (Ed.). The Rat Nervous System, Academic Press, San Diego, 1995, pp. 629-648.
45. 3H imipramine binding in male rat frontal cortex, Eur. J. Pharmacol., 107 (1985) 395-396.
46. [46] Reid, R.L. and Yen, S.S.C., Premenstrual syndrome, Am. J. Obstet. Gynecol., 139 (1981) 85-104.
47. [47] Renner, K.J., Krey, L.C. and Luine, V.N., Effect of progesterone on monoamine turnover in the brain of the estrogen-primed rat, Brain Res. Bull., 19 (1987) 195-202.
48. 1 adrenergic mechanism mediates estradiol stimulation of LHRH mRNA synthesis and estradiol inhibition of POMC mRNA synthesis in the hypothalamus of the prepubertal female rat, J. Steroid Biochem. Mol. Biol., 49 (1994) 399-406.
49. [49] Rosie, R., Wilson, H. and Fink, G., Testosterone induces an all-ornone, exponential increase in arginine vasopressin mRNA in the bed nucleus of stria terminalis of the hypogonadal mouse, Mol. Cell. Neurosci., 4 (1993) 121-126.
50. [50] Sakuma, Y. and Pfaff, W.D., Mesencephalic mechanisms for integration of female reproductive behavior in the rat, Am. J. Physiol., 237 (1979) R285-R290.
51. 3H]Imipramine binding in discrete brain areas is affected by castration in male rats, Brain Res., 496 (1989) 29-34.
52. [52] Steinbusch, H.W.M., Distribution of serotonin-immunoreactivity in the central nervous system of the rat-cell bodies and terminals, Neuroscience, 6 (1981) 557-618.
53. [53] Steinbusch, H.W.M. and Nieuwenhuys, R., The raphe nuclei of the rat brainstem: a cytoarchitectonic and immunohistochemical study. In P.C. Emson (Ed.), Chemical Neuroanatomy, Raven Press, New York, 1983, pp. 131-207.
54. 3H-imipramine binding sites in rat cerebral cortex, J. Recept. Res., 4 (1984) 755-771.
55. [55] Sumner, B.E.H. and Fink, G., Effects of acute estradiol on 5-hydroxytryptamine and dopamine receptor subtype mRNA expression in female rat brain, Mol. Cell. Neurosci., 4 (1993) 83-92.
56. 2A receptors in cerebral cortex and nucleus accumbens in the female rat, J. Steroid Biochem. Mol. Biol., 54 (1995) 15-20.